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Abstract. This study describes peptide fibre formation in a hexapeptide, derived from the V3 loop of 
HIV-1, mediated by the interactions between arginine residues and phosphate/carboxylate anions. This 
charge neutralization approach was further confirmed when the deletion of arginine residue from the 
hexapeptide sequence resulted in fibre formation, which was studied by a combination of microscopic 
techniques. 
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1. Introduction 
The process of peptide self-assembly, leading to fibre 
formation, critically depends on a subtle interplay of 
a variety of factors such as hydrogen bonding, hydro-
phobicity, π–π interactions, pH and electrostatic ef-
fects.
1
 The latter property, in particular, observed in 
amphiphilic peptide constructs and related systems 
has been ingeniously exploited to result in inte-
resting design paradigms useful for the construction 
of fibrous peptide-based materials2a–f and for surface 
deposition of peptides.
2g,h
 Charge neutralization bet-
ween acidic and basic amino acid side chains is the 
most common motif in such cases. 
 Chiti et al have recently reviewed that electro-
static charges are key factors in protein aggregation 
as a high net charge, either globally or locally, may 
hinder self-association.
3
 Various biological entities 
viz. proteins, certain RNA molecules and DNA mole-
cules fold into unique three-dimensional structures 
essential for their biological activity. In certain 
cases, the presence of counter ions facilitates neu-
tralization of electrostatic forces which may interfere 
with optimal folding process.
4
 Numerous examples 
of fibre formation through charge neutralization 
method are described in literature.
5
 For instance, one 
of the major factors responsible for the self-assembly 
of microtubule-associated tau protein is abnormal 
hyperphosphorylation. This phosphorylation event is 
responsible for the neutralization of inhibitory basic
charges, thus resulting in the self-assembly of tau 
protein into filamentous tangles.6 
 The third hypervariable region 3 (V3 loop) of HIV-
1 gp120 is a critical determinant of viral infectivity.7 
It contains a highly conserved hexapeptide sequence 
(319) GPGRAF possessing a double β-turn character 
in solution. We have previously studied peptide fibre 
formation in GPG palindrome, derived from this se-
quence, via a bis-conjugation approach where for-
mation of stable fibres was attributed to increased 
number of hydrogen bonding interactions in folded 
or extended conformation.
8
 In continuation, the pre-
sent study deals with GPGRAF hexapeptide where 
we demonstrate a combined beneficial effects of 
charge mitigation and extended hydrogen bonding 
interactions, as factors responsible for the growth of 
peptide fibres in a time-dependent fashion. 
 This hexapeptide sequence contains an arginine 
residue which is the most basic amongst all naturally 
occurring amino acids.9 Side chain guanidino group 
can participate both in electrostatic interactions and 
directed hydrogen bonds, through its planar, fork-like 
geometry.9 The carboxylate anion-guanidinium cation 
interaction is crucial in natural and non-natural sys-
tems as it allows stable, complementary ion-pair in-
teraction due to the formation of two hydrogen 
bonds. Charged groups, such as carboxylates and 
guanidiniums, are frequently encountered on the sur-
face of proteins and help solubilise these large mole-
cules in an aqueous environment. Additionally, these 
functionalities also play a critical role in tuning se-
lectivity of molecular interactions, recognition events 
and biological function.
10
 For example, arginine-
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containing alamethicin peptide displayed self-assem-
bly behaviour and the helix bundle channels thus 
formed exhibited remarkable anion-selectivity.11 
 The present work investigates bioinspired argin-
ine-phosphate/carboxylate interactions to enforce pep-
tide fibre formation via self-assembly process. Such 
charge mitigation approach also offers an intriguing 
possibility of biological anions inducing or assisting 
protein/peptide aggregation in vivo. 
2. Materials and methods 
All reactions, except saponification reactions, were 
performed under nitrogen atmosphere. Solvents like 
dichloromethane, N,N′-dimethylformamide, methanol 
were dried following the standard procedures prior 
to use. 1,2-diaminoethane was purchased from Lan-
caster and distilled before use. Triethylamine was 
purchased from S.D. Fine Chemicals Ltd. Mumbai, 
India, and distilled before use. N,N′-dicyclohexyl-
carbodiimide, was purchased from Spectrochem 
Pvt. Ltd., Mumbai, India used without further puri-
fication. 1-hydroxybenzotriazole which was pur-
chased from Spectrochem Pvt. Ltd. Mumbai, India, 
was recrystallized from 50% aqueous ethanol prior 
to use. 1H and 
13
C NMR were recorded on JEOL-
JNM LAMBDA 400 model operating at 400, 
100 MHz respectively. ESI High Resolution Mass 
spectra were recorded at Indian Institute of Techno-
logy Kanpur, India on a Waters, Q-ToF Premier 
micromass HAB 213 mass spectrometer using 
capillary voltage 2⋅6–3⋅2 kV. Sample concentration 
were 1 mM (1 mg of sample was dissolved in 1 mL 
methanol) and 10 μL of the sample prepared was 
injected. Melting points of the compounds deter-
mined are uncorrected (Navyug India Limited). The 
precursor penta- and hexapeptides were synthesized 
via routine solution-phase methods and will be re-
ported elsewhere. 
2.1 Synthesis of peptides 
2.1a Synthesis of H2N–Gly–Pro–Gly–Arg–Ala–
Phe–COOH (1): Boc–GPGR(Tos)AF–OH (0⋅1 g, 
0⋅11 mmol) was completely dissolved in dichloro-
methane (2 mL), then added few drops of trifluoro-
methane sulphonic acid and stirred for 3 h. After this 
time, the solvent was evaporated under reduced 
pressure. The gummy compound triturated with di-
ethyl ether and the round bottomed flask was kept in 
an ice bath. After sometime ether was decanted and 
this process repeated till the gummy compound be-
comes solid. This solid compound was dissolved in 
50% aqueous methanol (2 mL) and passed through 
an anion exchange column to get pure 1 (0⋅05 g, 80%). 
The compound was hygroscopic and prevented the 
(accurate) determination of its melting point. [α]Dt = 
–45° (c = 0⋅73 in 50% aqueous methanol, t = 25°C). 
HRMS: found (M + 1) = 604⋅3204; C27H42N9O7 re-
quires 604⋅3207 [ESI +ve mode]. 
1
H NMR: (400 MHz, 
D2O, 25°C) δ (ppm) 1⋅15 (d, Ala, –CH3); 1⋅6, 1⋅8 
and 2⋅1 (m, for guanidine 6H and Pro β, γ 4H); 2⋅9 
and 3⋅1 (m, Phe 2 βH); 3⋅3, 3⋅75 and 3⋅93 (m, Gly 
4H and Pro 2 δ H); 4⋅10, 4⋅3 and 4⋅63 (m, 4α H of 
Pro, Arg, Ala and Phe); 7⋅01, 7⋅03, 7⋅14 and 7⋅17 (m, 
for Phe protons). 
13
C NMR: (100 MHz, D2O, 25°C) 
δ (ppm) 17⋅43, 25⋅14, 30⋅18, 38⋅24, 41⋅34, 43⋅41, 
47⋅49, 50⋅41, 53⋅80, 56⋅86, 61⋅38, 125⋅93, 126⋅64, 
126⋅88, 127⋅52, 129⋅25, 130⋅22, 138⋅11, 157⋅42, 
172⋅14, 173⋅91, 174⋅19, 176⋅32, 178⋅14. 
 
2.1b Synthesis of H2N–Gly–Pro–Gly–Ala–Phe–
COOH (2): Boc–GPGAF–OH (0⋅1 g, 0⋅18 mmol) was 
dissolved in 50% TFA–DCM (2 mL) and then stirred 
for 2⋅5 h, and then solvent was evaporated under redu-
ced pressure. The obtained gummy compound was 
triturated with diethyl ether and the round bottomed 
flask was kept in an ice bath. After sometime the ether 
was decanted and this process repeated till the gummy 
compound becomes solid. This solid compound was 
dissolved in 50% aqueous methanol (2 mL) and pas-
sed through an anion exchange column to get pure 2 
(0⋅06 g, 80%). The compound was hygroscopic and 
prevented the (accurate) determination of its melting 
point. [α]Dt = –50° (c = 0⋅6 in 50% aqueous methanol, 
t = 25°C). HRMS: found (M + 1) = 448⋅2192; 
C21H30N5O6 requires 448⋅2196 [ESI +ve mode]. 
1
H 
NMR: (400 MHz, D2O, 25°C) δ (ppm) 1⋅14 (d, Ala,  
–CH3); 1.88 and 2⋅14 (m, Pro β, γ 4H); 2⋅93 (m, Phe 
2β H); 3.36 (m, Pro δ H); 3⋅67, 3⋅71 and 3⋅96 (m, 4 
Gly H); 4⋅25, 4⋅35 and 4⋅7 (m, 3α H of Pro, Ala and 
Phe); 6⋅98 (d), 7⋅00, 7⋅05, 7⋅20 (m, corresponding to 
Phe aromatic protons)⋅ 13C NMR (100 MHz, D2O, 
25°C) δ (ppm) 17⋅53, 25⋅72, 29⋅17, 30⋅22, 38⋅38, 
43⋅01, 47⋅54, 50⋅20, 56⋅87, 61⋅42, 126⋅64, 127⋅46, 
129⋅91, 130⋅15, 130⋅51, 157⋅76, 171⋅85, 174⋅05, 
175⋅79, 178⋅23. 
 
2.1c Synthesis of Bis(Gly–Pro–Gly–Arg–Ala–Phe) 
diaminoethane (3): The protected bisconjugate of the 
hexapeptide (0⋅04 g, 0⋅02 mmol) was dissolved in dry 
dichloromethane (2 mL), stirred for 10 min and after 
completely forming a clear solution, 0⋅3 mL of tri-
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fluoromethane sulphonic acid was added and stirred 
for 3 h. After this time, the solvent was evaporated 
under reduced pressure. The syrupy residue was tri-
turated with diethyl ether, and the round bottomed 
flask was kept in an ice bath. After sometime ether 
was decanted and this process repeated till the gummy 
compound becomes solid. The solid was dissolved in 
50% aqueous methanol (3 mL) and passed through an 
anion exchange column to get pure 3 (0⋅02 g, 81%). 
The compound was hygroscopic and prevented the 
(accurate) determination of its melting point. [α]Dt = 
44⋅4° (c = 0.45 in methanol, t = 25°C). HRMS: found 
(M + 2) = 1233.6913; while C56H88N20O12 requires 
1233⋅6972 [ESI +ve mode]. 
1
H NMR: (400 MHz, 
D2O, 25°C) δ (ppm) 1⋅07 (d, Ala –CH3); 1⋅36, 1⋅53, 
1⋅70 (m, for guanidine 6H and Pro β, γ 4H); 2⋅78 to 
3⋅4 (m, Phe 2βH, 2H of DAE, Pro δ 2H, gly 4H); 3⋅99 
and 4⋅18 (m, 4α H of Pro, Arg, Ala and Phe); 6⋅99 and 
7⋅07 (m, aromatic protons of Phe). 
13
C NMR: (100 
MHz, D2O, 25°C) δ (ppm) 17⋅14, 23⋅06, 24⋅98, 25⋅10, 
28⋅88, 30⋅12, 32⋅30, 37⋅95, 43⋅40, 50⋅37, 53⋅97, 55⋅95, 
61⋅43, 62⋅57, 127⋅90, 129⋅45, 125⋅95, 137⋅16, 157⋅44, 
166⋅57, 173⋅46, 175⋅08, 176⋅06, 176⋅45, 180⋅21, 
180⋅63. 
 
2.1d Synthesis of Bis (Gly–Pro–Gly–Ala–Phe) 
diaminoethane (4): Deprotection of protected bis 
pentapeptide (0⋅3 g, 0⋅27 mmol) was achieved by 
dissolving in 4 mL of 50% TFA–DCM mixture, 
stirred for 3 h and then evaporated the solvent under 
reduced pressure. The gummy compound triturated 
with diethyl ether and the round bottomed flask was 
kept in an ice bath. After sometime ether was de-
canted and this process repeated till the gummy com-
pound becomes solid. This solid compound was 
dissolved in 3 mL 50% aqueous methanol and passed 
through an anion exchange column to get pure 4 
(0⋅23 g, 58%). The compound was hygroscopic and 
prevented the (accurate) determination of its melting 
point. [α]Dt = 33⋅3° (c = 0.3 in water, t = 25°C). 
HRMS: (M + Na) = 941⋅4611 while C44H62O10N12Na 
requires 941⋅4610 [ESI +ve mode]. 
1
H NMR: 
(400 MHz, D2O, 25°C) δ (ppm) 1⋅12 (d, Ala –CH3); 
1⋅75–1⋅85 and 2⋅06–2⋅13 (m, Pro β, γ 4H); 2⋅82–3⋅11 
(m, Phe 2β H and DAE 2H); 3⋅3, 3⋅4 and 3⋅7 (m, for 
Gly 4H and Pro δ H) 4⋅09, 4⋅26 and 4⋅38 (m, 3α H of 
Pro, Phe, Ala); 7⋅08–7⋅22 (m, 5H of Phe)⋅ 13C NMR 
(100 MHz, D2O, 25°C) δ (ppm) = 26⋅39, 27⋅46, 39⋅69, 
43⋅07, 43⋅41, 44⋅51, 55⋅56, 109⋅55, 112⋅68, 119⋅02, 
120⋅17, 122⋅78, 125⋅20, 127⋅59, 136⋅87, 171⋅21, 
171⋅55, 172⋅14, 172⋅85, 174⋅76. 
2.1e FPLC Studies: The peptide conjugates 3 and 4 
are found to be pure when run through a μRPC 
C2/C18 ST4.6/100 column with an applied gradient of 
50% methanol-water system with 1 mL/min flow rate. 
The FPLC used here is an analytical FPLC (Akta 
Basic, Amersham Pharmacia). The concentration of 
the conjugates for an analytical run is 1 mg/ml and the 
purity of peptides and their conjugates was >95%. 
 
2.1f Scanning Electron Microscopy: 15 μL of 4 
(5 mM, 20 days aged diluted to 1 mM as final con-
centration), 3 in phosphate buffer (5 mM pH = 7⋅0, 
15 d aged diluted to 1 mM), 3-ADP and 3-ATP com-
plexes (5 mM, 1 :
 
1 ratio, diluted to 1 mM as the  
final concentration, 20 d aged) were dried on a clean 
brass stub and gold coated for 1 h and then used for 
SEM imaging. SEM imaging was accomplished with 
FEI Quanta 200 instrument operated with a voltage of 
20 kV. The samples of aged peptides 1 and 2 were 
also prepared following the same procedure as men-
tioned above. 
 
2.1g Atomic force microscopy: 15 μL of 20 days 
aged solution of 4 (5 mM but diluted to 1 mM dur-
ing sample preparation), 15 μL of ~20 days aged so-
lutions of 3-succinic acid (5 mM, 1 :
 
1 ratio, diluted 
to 1 mM as the final concentration) 3-glutaric acid 
(5 mM, 1 :
 
1 ratio, diluted to 1 mM as the final con-
centration), 3 in phosphate buffer alone (5 mM 
pH = 7⋅0, 15 d aged diluted to 1 mM) were trans-
ferred on to freshly cleaved mica pieces (3 × 5 μL). 
These mica pieces were dried for a period of 10 min 
under a table lamp (100 W) followed by imaging 
with atomic force microscope (Molecular Imaging, 
USA), operated under Acoustic AC mode (AAC) 
with the aid of cantilever (NSC36, Mikro Masch). 
The force constant was 0⋅6 N/m, while the resonant 
frequency used was 150 kHz. The images were taken 
in air at room temperature, with a scan speed of 1⋅5–
2⋅2 lines/s. Data acquisition was performed by Pico 
Scan 5 software and the analysis was done with the 
aid of visual SPM. 
 
2.1h Optical microscopy: Congo red solution 
(2 μL, 50 μM saturated solution in 80% ethanol/ 
water) was added to aged solutions of 4 (23 μL, 
5 mM), 3 in phosphate buffer (23 μL, 5 mM), 3-
succinic acid, 3-glutaric acid (23 μL, 5 mM) and 3-
ATP (23 μL, 5 mM) and the mixture sonicated for 
8 s and left for 6 h at 37°C. These solutions were 
then transferred on to clean glass slides, dried and
K Krishna Prasad and Sandeep Verma 
 
158 
 
 
Figure 1. AFM micrographs of aged samples and cross-sections of (a) 2 (~30 nm); (b) 1-ATP (~90 nm) and (c) 1-
glutaric acid (~15 nm). (Arrowheads indicate the branching points). 
 
 
 
 
Figure 2. Molecular structures of peptide conjugates, 3 
and 4. 
 
 
then viewed under optical microscope (Labomed, 
Digi 3, 10X) with cross-polarized light, interfaced 
with a PC. Images were obtained by using a CCD 
camera attachment and processed with the help of 
Digipro V 2.0 software. 
3. Results and discussion 
Initial experiments involved the study of aggregative 
behaviour of the full hexapeptide GPGRAF (1) and 
a control GPGAF (2) pentapeptide sequence with 
arginine deletion to ascertain its role, if any, in the 
formation of stable peptide fibres upon aging. Inter-
estingly, ~ 45 days incubation of 1 and 2 (5 mM in 
each case) in pure water at 37°C revealed fibre for-
mation in 2, (formation of protofilaments observed 
after 10 d; data not shown) lacking the arginine resi-
due (figure 1a), while 1 alone did not reveal distinct 
fibre formation perhaps due to the electrostatic re-
pulsion between the two guanidino side chains (data 
not shown). However, 1 alone could only afford 
poorly structured oligomeric aggregates when its 
aqueous solution was aged for 45 days (data not 
shown). Thus, we decided to counter this structural 
(charge) lacuna with the help of biologically rele-
vant anions such as phosphates and carboxylates. 
The premise of charge neutralization was validated 
when 1 self-assembled in the presence of ATP and 
glutaric acid (2⋅5 mM as final concentration), re-
vealing emergence of peptide fibres at the end of 45 
days (figure 1b, c). 
 We have been experimenting with the beneficial 
effects of linked bis- and tris-peptide conjugates 
where self-assembly is accentuated due to increased 
number of non-covalent stabilizing interactions, such 
as hydrogen bond and π–π interactions.8,12 In a related 
example, we were able to enforce aggregation in a 
truncated V3 loop GPG tripeptide when conjugated to 
1,2-diaminoethane (DAE).8 Thus, it was of interest to 
determine whether this linker, in combination with 
charge neutralization, would further control emergence 
of peptide fibres through self-assembly. Two bis-
conjugates, (GPGRAF)2 DAE (3) and (GPGAF)2 
DAE (4) (figure 2) were synthesized using solution 
phase protocols. 
 Preliminary aging experiments with 3 and 4 were 
concurrent to our observations with 1 and 2. Argin-
ine-containing hexapeptide conjugate 3 (5 mM) 
failed to reveal fibres upon incubation in water (fig-
ure 3a), while the arginine-deleted bis construct 4
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Figure 3. Aging studies with bis conjugates. (a) AFM micrograph of aged 3 displaying punctuated 
structures suggesting lack of aggregation; (b–d) AFM (~20 nm) and SEM micrographs and optical  
micrograph of Congo red-stained image of individual peptide fibre from aged solution of 4. 
 
 
 
 
Figure 4. (a) AFM image of aged 3 (fibre cross-section: ~90 nm) in the presence of phosphate 
buffer (arrowheads indicate branching points); (b) SEM image of mature 3 fibres in phosphate buffer. 
 
(5 mM), afforded dense fibrillation within ~20  
days of incubation in water at 37°C (figure 3b–d). 
This observation suggested that bis-scaffolds  
reduced the aggregation time by half possibly
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Figure 5. SEM images peptide fibre from incubation of 3 with (a) ADP; and (b) ATP; AFM images of 
peptide fibres from incubation of 3 with (c) succinic acid (~140 nm) and (d) glutaric acid (~20 nm). Ar-
rowheads indicate branching points. 
 
 
by enhancing the number of stabilizing interac- 
tions. 
 Importantly, we were able to force aggregation in 
3 (5 mM) in the presence of simple phosphate buffer 
(5 mM, pH = 7⋅0), where self-assembled structures 
were observed within 15 days of incubation (figure 
4). Branching of fibrils in phosphate buffer was ob-
served in AFM (figure 4a). Natural protein fibres, 
such as those formed by actin, collagen and fibrin also 
form branches. Formation of branches in self-
assembling filaments has been reported by Woolfson 
and coworkers.13 
 Encouraged by these results, we probed nucleo-
tides for their ability to induce aggregation. SEM 
micrographs revealed facile self-assembly of 3-ADP 
and 3-ATP complexes (5 mM as final concentration 
of 3 and corresponding nucleotides), culminating 
into fibre formation (figure 5a, b). Such an interac-
tion between phosphate groups and an arginine moi-
ety was recently reported for the self-assembly of 
peptide amphiphiles.2e The interaction between gua-
nidinium and phosphate groups is generally attributed 
to a combined effect of electrostatics and hydrogen 
bonding.
14
 Frankel and co-workers, while studying 
HIV-1 Tat protein and TAR RNA interaction, have 
also described the role of an arginine moiety for 
RNA binding.15 Another literature example has de-
scribed interaction of adenine nucleotides with posi-
tively charged residues, such as arginine and lysine, 
in the case of a pore-forming protein.
16,17
 
 The guanidinium group can also bind to other 
anionic species such as carboxylates.18–20 On the lines 
of arginine-phosphate interaction, incubation of 3 in 
the presence of diacids such as succinic and glutaric 
acid (5 mM as final concentration of 3 and corre-
sponding diacids) resulted in peptide fibre formation 
(figure 5c, d). Interestingly, diacid induced fibres 
also displayed branched features similar to the struc-
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tures observed in the phosphate buffer (figure 5c, d). 
We also resorted to optical microscopy to capture 
the occurrence of Congo-red stained fibres which 
once again confirmed the presence of peptide fibres 
due to electrostatic effects manifested by arginine-
anion interactions (figure 6). 
 Induction of peptide assembly solely on the basis of 
charge neutralization can be understood by a simple 
model which also suggests reasons through which 
fibril growth and branching may occur (scheme 1). 
Lateral overlaps are expected to elongate peptide fibre 
growth in a given direction, while spatial predisposi-
tion of phosphates and carboxylates and tethering of 
two growing chains may eventually result in the 
 
 
 
 
Figure 6. The phenomenon of green-birefringence of 3 
with (a) succinic acid (b) glutaric acid, (c) phosphate 
buffer alone and (d) ATP. 
 
 
 
 
Scheme 1. Proposed model of electrostatic neutraliza-
tion of arginine moieties on peptide chains by anions (red 
dumbbells) and lateral association to give self-assembled 
fibres of persistent length. 
emergence of the branchpoints. It is expected that a 
suitable choice of anions may result in interesting ultra-
structural morphologies of self-assembled peptides. 
 Interestingly, neutralization of arginine residues 
via salt bridges is reported for HIV-1 interaction 
with antibodies and arginine interaction with sul-
phated proteoglycans, for the infection of macro-
phages and T-cell lymphocytes.21 
4. Conclusions 
This study entails a bioinspired approach in enforc-
ing peptide aggregation via neutralization of positive 
charges on the arginine residues and applies electro-
statics based design paradigm for the construction of 
peptide fibres and filaments, with a distinct depend-
ence on flexible linkers for an accelerated self-
assembly process. The study of the properties of 
peptide nanofibrillar assemblies and the mechanisms 
of formation might be a source of inspiration for the 
development of ordered, rationally designed nano-
structures with potentially interesting applications.
22 
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